Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Indonesia
51%
First-degree Relatives
40%
Insulin Resistance
37%
Graves' Disease
30%
Jakarta
23%
Indonesian
20%
Referral Hospital
19%
Type 2 Diabetic Patients
19%
Type 1 Diabetes Mellitus (T1DM)
18%
Obesity
18%
Dendritic Cells
17%
Clinical Practice Guidelines
17%
Diabetes
17%
Subclinical Atherosclerosis
17%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
17%
Periodontitis
17%
Randomized Placebo-controlled Trial
17%
Grip Strength
17%
Growth Factors
16%
Insulin-like
16%
Carotid Intima-media Thickness (cIMT)
15%
Risk Factors
14%
Interleukin-6
12%
Hypertension
11%
Hyperglycemia
11%
Nonerosive Reflux Disease
11%
Non-communicable Disease Risk Factors
11%
Family History of Type 2 Diabetes
11%
Risk-based Surveillance
11%
Non-alcoholic Fatty Liver Disease (NAFLD)
11%
CMV Seropositivity
11%
Lessons Learned
11%
Postmenopausal Women
11%
COVID-19 Pandemic
11%
Frail Elderly
11%
High-fat Diet
11%
HIV Patients
11%
Atorvastatin
11%
Pre-frail
11%
Dyslipidemia
11%
Non-communicable Diseases
11%
Interleukin-10
10%
Central Obesity
10%
Gastroesophageal Reflux Disease
9%
Diabetic Patients
9%
Cardiovascular Disease
9%
Hemoglobin A1c (HbA1c)
8%
Immune Activation
8%
Pre-diabetes (pre-DM)
8%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
77%
Diabetes
45%
Insulin Resistance
36%
Diabetes Mellitus
27%
Atherosclerosis
20%
Periodontitis
17%
Placebo
17%
Body Mass Index
16%
Cross Sectional Study
15%
Hand Grip Strength
15%
COVID-19
14%
Homeostatic Model Assessment
13%
Hemoglobin A1c
12%
Human Immunodeficiency Virus
12%
Patient Referral
12%
Intima-Media Thickness
12%
Gastroesophageal Reflux
11%
Adiponectin
11%
Atorvastatin
11%
Somatomedin C
11%
High Fat Food
11%
Cardiovascular Disease
8%
Uric Acid
8%
Non Communicable Disease
7%
Blood Pressure
7%
Glycemic Control
7%
Bone Turnover
7%
Type 2 Diabetes
7%
Walking Speed
7%
Diseases
7%
Family History
6%
Beta Cell
6%
Middle Age
6%
Adipocytokine
6%
Hand Grip
5%
Hyperpigmentation
5%
Iron Overload
5%
Elderly Patient
5%
Premenopause
5%
Orthostatic Hypotension
5%
Immune Response
5%
Opportunistic Infection
5%
Nonalcoholic Fatty Liver
5%
Primary Health Care
5%
Endocrine Ophthalmopathy
5%
Adenoma
5%
Cell Function
5%
Vitamin D Receptor
5%
Patient with Diabetes
5%
Fatty Acid Binding Protein 2
5%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
52%
Diabetes Mellitus
28%
Insulin Resistance
25%
Graves Disease
24%
Atherosclerosis
21%
Placebo
18%
Somatomedin C
17%
Periodontitis
17%
Non Communicable Disease
13%
Hemoglobin A1c
11%
Diseases
11%
Adiponectin
11%
Nonalcoholic Fatty Liver
11%
Atorvastatin
11%
Syndrome
11%
HIV
11%
Metabolic Syndrome X
11%
Prevalence
10%
Cross-Sectional Study
10%
Interleukin 10
10%
Hyperglycemia
10%
Triacylglycerol
9%
Cardiovascular Disease
9%
Cytokine
9%
Inflammation
7%
Vitamin D
7%
Interferon
6%
Prospective Study
6%
Hyperuricemia
6%
Adenosine Triphosphate
6%
Adipocytokine
6%
High Density Lipoprotein Cholesterol
6%
Cholecalciferol
5%
Methimazole
5%
Heart Arrhythmia
5%
Prospective Cohort Study
5%
Beta Thalassemia
5%
Disease Exacerbation
5%
Fatty Acid Binding Protein 2
5%
Endocrine Ophthalmopathy
5%
Gastroesophageal Reflux
5%
Interleukin 6 Receptor
5%
Orthostatic Hypotension
5%
Vitamin D Receptor
5%
Thyroid Nodule
5%
Randomized Clinical Trial
5%
Liver Injury
5%
Sclerostin
5%
Growth Retardation
5%
Hypogonadism
5%